150 related articles for article (PubMed ID: 33076804)
1. Elucidation of the Mechanisms and Molecular Targets of Qishen Yiqi Formula for the Treatment of Pulmonary Arterial Hypertension using a Bioinformatics/Network Topology-based Strategy.
Wu P; Xie X; Chen M; Sun J; Cai L; Wei J; Yang L; Huang X; Wang L
Comb Chem High Throughput Screen; 2021; 24(5):701-715. PubMed ID: 33076804
[TBL] [Abstract][Full Text] [Related]
2. [Molecular mechanism of Qishen Yiqi Dripping Pills in treating myocardial ischemia:a study based on HIF-1 signaling pathway].
Gong YT; Li YP; Cheng YR; Shi XJ; Yang L; Yang DP; Xu WJ; Dong L
Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(15):3949-3959. PubMed ID: 34472272
[TBL] [Abstract][Full Text] [Related]
3. An integrated evidence-based targeting strategy for determining combinatorial bioactive ingredients of a compound herbal medicine Qishen Yiqi dripping pills.
Zhang Y; Yu J; Zhang W; Wang Y; He Y; Zhou S; Fan G; Yang H; Zhu Y; Li P
J Ethnopharmacol; 2018 Jun; 219():288-298. PubMed ID: 29572106
[TBL] [Abstract][Full Text] [Related]
4. Network pharmacology and molecular docking prediction, combined with experimental validation to explore the potential mechanism of Qishen Yiqi pills against HF-related cognitive dysfunction.
Han SJ; Xu QQ; Pan H; Liu WJ; Dai QQ; Lin HY; Cui HR; You LZ; Wu YZ; Wei XH; Shang HC
J Ethnopharmacol; 2023 Oct; 314():116570. PubMed ID: 37187360
[TBL] [Abstract][Full Text] [Related]
5. Qishen Yiqi Drop Pill, a novel compound Chinese traditional medicine protects against high glucose-induced injury in cardiomyocytes.
Zhang S; Wang H; Li L; Chang X; Ma H; Zhang M; Qing X; Zhang L; Zhang Z
J Cell Mol Med; 2019 Sep; 23(9):6393-6402. PubMed ID: 31278860
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the mechanism of the reduction of anthracycline-induced cardiotoxicity by Qishen Huanwu Capsule based on network pharmacology.
Wang F; Wang L; Liu F; Meng L; Zhao N; Zhai X; Liu H; Yang J
Ann Palliat Med; 2021 Jan; 10(1):16-28. PubMed ID: 33474949
[TBL] [Abstract][Full Text] [Related]
7. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S
Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
[TBL] [Abstract][Full Text] [Related]
8. QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology.
Li M; Wang Y; Qi Z; Yuan Z; Lv S; Zheng Y; Yan Z; Wang M; Fu H; Fan X; Ji N; Liu M; Fang Z
Front Pharmacol; 2022; 13():981206. PubMed ID: 36164369
[No Abstract] [Full Text] [Related]
9. Potential mechanisms of Qili Qiangxin capsule to prevent pulmonary arterial hypertension based on network pharmacology analysis in a rat model.
Han X; Li C; Yang P; Jiang T
Ann Transl Med; 2022 Apr; 10(8):453. PubMed ID: 35571420
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of the Mechanisms and Molecular Targets of Yiqi Shexue Formula for Treatment of Primary Immune Thrombocytopenia Based on Network Pharmacology.
Jiang Y; Liu N; Zhu S; Hu X; Chang D; Liu J
Front Pharmacol; 2019; 10():1136. PubMed ID: 31632275
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids.
Yu Y; Yang F; Liu H
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33196098
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.
Cao Z; Zeng Z; Wang B; Liu C; Liu C; Wang Z; Li S
J Ethnopharmacol; 2021 Jan; 264():113289. PubMed ID: 32846191
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of the Mechanisms and Molecular Targets of
Xu M; Li Z; Yang L; Zhai W; Wei N; Zhang Q; Chao B; Huang S; Cui H
Biomed Res Int; 2020; 2020():5848497. PubMed ID: 32851081
[No Abstract] [Full Text] [Related]
14. The Mechanism Research of Qishen Yiqi Formula by Module-Network Analysis.
Zheng S; Zhang Y; Qiao Y
Evid Based Complement Alternat Med; 2015; 2015():497314. PubMed ID: 26379745
[TBL] [Abstract][Full Text] [Related]
15. A network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action.
Li X; Wu L; Liu W; Jin Y; Chen Q; Wang L; Fan X; Li Z; Cheng Y
PLoS One; 2014; 9(5):e95004. PubMed ID: 24817581
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the multicomponent synergy mechanisms of SiNiSan prescription on irritable bowel syndrome using a bioinformatics/network topology based strategy.
Li B; Rui J; Ding X; Chen Y; Yang X
Phytomedicine; 2019 Oct; 63():152982. PubMed ID: 31299593
[TBL] [Abstract][Full Text] [Related]
17. Qishen Yiqi Dripping Pills for Cardiovascular Diseases: Effects and Mechanisms.
Lu CM; Yang YS; Lu YM; Zhu YP; Zhang A; Lyu SC; Zhang JP
Chin J Integr Med; 2023 Sep; 29(9):857-864. PubMed ID: 36301453
[TBL] [Abstract][Full Text] [Related]
18. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
[TBL] [Abstract][Full Text] [Related]
19. Hydroxy-Safflower Yellow A Mitigates Vascular Remodeling in Rat Pulmonary Arterial Hypertension.
Ji XY; Lei CJ; Kong S; Li HF; Pan SY; Chen YJ; Zhao FR; Zhu TT
Drug Des Devel Ther; 2024; 18():475-491. PubMed ID: 38405578
[TBL] [Abstract][Full Text] [Related]
20. BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine.
Liu Z; Guo F; Wang Y; Li C; Zhang X; Li H; Diao L; Gu J; Wang W; Li D; He F
Sci Rep; 2016 Feb; 6():21146. PubMed ID: 26879404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
